KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hims & Hers Health (HIMS) EBIT (2020 - 2025)

Historic EBIT for Hims & Hers Health (HIMS) over the last 6 years, with Q3 2025 value amounting to $11.8 million.

  • Hims & Hers Health's EBIT fell 4722.89% to $11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $115.0 million, marking a year-over-year increase of 16807.51%. This contributed to the annual value of $61.9 million for FY2024, which is 31017.55% up from last year.
  • Hims & Hers Health's EBIT amounted to $11.8 million in Q3 2025, which was down 4722.89% from $26.7 million recorded in Q2 2025.
  • In the past 5 years, Hims & Hers Health's EBIT registered a high of $57.9 million during Q1 2025, and its lowest value of -$48.4 million during Q1 2021.
  • Its 5-year average for EBIT is -$2.9 million, with a median of -$9.2 million in 2023.
  • As far as peak fluctuations go, Hims & Hers Health's EBIT plummeted by 167803.88% in 2021, and later skyrocketed by 474900.0% in 2024.
  • Over the past 5 years, Hims & Hers Health's EBIT (Quarter) stood at -$21.6 million in 2021, then surged by 46.19% to -$11.6 million in 2022, then surged by 96.55% to -$400000.0 in 2023, then skyrocketed by 4749.0% to $18.6 million in 2024, then tumbled by 36.51% to $11.8 million in 2025.
  • Its last three reported values are $11.8 million in Q3 2025, $26.7 million for Q2 2025, and $57.9 million during Q1 2025.